Lab Coworker Escalates A Simple Labeling Mistake To Management, So The New Barcode System Adds Hours To His Own Workload

A medicinal chemist at a biotech company decided to take matters into his own hands after a coworker escalated a simple labeling mistake to management. What could have been a minor error turned into a ...
BioSpace

Biotech’s China problem: An issue of national security or economic value for the US?

Congressional letters sent to the CEOs of Eli Lilly, Pfizer, Merck, BMS and AbbVie this week voicing concerns about the pharmas’ clinical trials in China highlight an ongoing discrepancy in how ...

US startup creates human egg cells from stem cells, but trials years away

US-based Conception said more work is needed to grow the eggs to full maturity, but called the achievement a 'major ...
University of Nevada, Reno

What Botox, rat poison and venoms can teach students about science – and careers

What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...

Innovation is the Best Medicine: How CEO Shane Schaffer and Cingulate Developed “Precision Timed Release,” a New Drug Delivery Platform for ADHD

ADHD patients deserved a more consistent, safe and manageable medication experience. Imagining a better way forward, they ...
Nature

Making samples one billion times bigger lets simple microscopes pinpoint amino acids

Stretching protein samples in all directions pulls molecules farther apart, allowing them to be visualized using only light ...

Biotech IPO revival faces competition from cash-rich big pharma buyers

Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.
The New York Times

China’s Rise in Drug Development Looms Over U.S.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...
Morningstar

A Wave of Biotech IPOs May Be Starting—Here’s Why

Biopharma companies appear to be more willing to go public after a long drought. Just this week, GLP-1 developer Kailera Therapeutics and proteomics company Alamar Biosciences launched IPO roadshows ...

Standard BioTools Inc.

View Standard BioTools Inc. LAB stock quote prices, financial information, real-time forecasts, and company news from CNN.

Lexaria Bioscience Corp.

View Lexaria Bioscience Corp. LEXX stock quote prices, financial information, real-time forecasts, and company news from CNN.